DYSLIPIDEMIAS
Clinical trials for DYSLIPIDEMIAS explained in plain language.
Never miss a new study
Get alerted when new DYSLIPIDEMIAS trials appear
Sign up with your email to follow new studies for DYSLIPIDEMIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection aims to tackle high cholesterol in early human trial
Disease control Not yet recruitingThis early-stage trial tests a single injection of MWX205 in 37 adults with high cholesterol or blood fats (dyslipidemia). Researchers will check if the drug is safe, how the body processes it, and how it affects cholesterol levels compared to a placebo. The goal is to find the r…
Matched conditions: DYSLIPIDEMIAS
Phase: PHASE1 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New injection targets hidden heart risk in early trial
Disease control Not yet recruitingThis early-stage study tests a single dose of BSA204, an experimental injection, in 40 Chinese adults with borderline high lipoprotein(a) – a fatty substance linked to heart disease. The main goal is to check safety and side effects, while also measuring changes in cholesterol le…
Matched conditions: DYSLIPIDEMIAS
Phase: PHASE1 • Sponsor: Bisirna Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can a simple WhatsApp message save lives? chile tests new screening nudge
Knowledge-focused Not yet recruitingThis study will send different types of WhatsApp messages to 235,000 people in Chile who are due for cancer or chronic disease screenings. Researchers want to see if the way a message is worded (basic, risk-focused, or peace-of-mind) and whether it mentions one test or both tests…
Matched conditions: DYSLIPIDEMIAS
Phase: NA • Sponsor: University of Chile • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC